Abdulla Shehab
Abdulla Shehab is an expert in Cardiology at Islamic Azad University, UAE Branch (United Arab Emirates). Abdulla Shehab has authored 146 publications, the most recent in 2026, and is an investigator in 2 clinical trials. SLR score: 396 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Pulmonology - Nutrition - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 146
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Vericiguat: The Fifth Pillar of Heart Failure. PMID 42416584 — heart failure, heart | Rev Cardiovasc Med | 2026 | 0 |
| Risk prediction and prevention in patients with advanced subclinical atherosclerosis. PMID 42141396 — cardiovascular diseases, aspirin, atherosclerosis, ultrasonography, carotid arteries | BMC Cardiovasc Disord | 2026 | 0 |
| Drug-eluting balloons versus drug-eluting for de novo coronary lesions with large-vessel focus: a narrative review. PMID 42044784 — stents, paclitaxel, pharmaceutical preparations, cardiology, wounds and injuries | Am J Cardiol | 2026 | 0 |
| Intervening Early in the Cardiovascular-Kidney-Metabolic Syndrome: Expert Recommendations from the United Arab Emirates on the Management of Prediabetes. PMID 41783738 — diabetes mellitus, blood glucose, blood, cardiovascular diseases, kidney, risk management, prediabetic state, vascular diseases, diagnosis, therapeutics, diabetes complications, metabolic syndrome | Vasc Health Risk Manag | 2026 | 0 |
| Strategies for the Prevention and Management of Respiratory Infections in Patients at High Risk in the UAE: A Cross-Disciplinary Position Paper. PMID 40684072 — research design, respiratory syncytial viruses, vaccines, respiratory tract infections, vaccination, therapeutics, antiviral agents, infections | Pulm Ther | 2025 | 2 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map